Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • acricketeer acricketeer Mar 19, 2013 8:33 PM Flag

    4 Clinical Trials Supervised by Data Safety Monitoring Board

    Pearl 1 and 2 and Emerald 1 and 2. 2 trials in chronic kidney disease and 2 in end-stage renal disease.No reports of serious allergic reactions or anaphylaxis. New England Journal of Medicine January 24, 2013. Emerald 1 enrolled 803 patients and Emerald 2- 823 patients.

 
AFFY
0.1114+0.0004(+0.36%)Mar 27 3:50 PMEDT